Obstructive Sleep Apnea Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Endotypic Traits and Obstructive Sleep Apnea Surgery
Condition:   Obstructive Sleep Apnea Interventions:   Drug: Acetazolamide 500 MG QHS;   Drug: Eszopiclone 3 mg QHS Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Use of the ExVent Accessory With the O2Vent Optima Oral Appliance for the Treatment of Obstructive Sleep Apnea
Conditions:   Sleep Apnea, Obstructive;   Sleep-Disordered Breathing Intervention:   Device: ExVent Sponsor:   Centre for Sleep and Chronobiology, Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials

Obersvational Study on Effects of CPAP on Depressive Symptoms in OSAS
Condition:   Sleep Apnea Intervention:   Behavioral: Questionnaire Sponsor:   Portsmouth Hospitals NHS Trust Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials